stage iv breast cancer
Showing 51 - 75 of 167
Stage IV Prostate Cancer, Stage IV Colon Cancer, Stage IV Breast Cancer Trial in Kingston (Dibenzyl trisulphide capsules, Stage
Unknown status
- Stage IV Prostate Cancer
- +3 more
- Dibenzyl trisulphide capsules
- +4 more
-
Kingston, JamaicaFaculty of Medial Sciences
Oct 3, 2019
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Ramat-Gan, Lampang (BP-C1)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
-
Ramat-Gan, Israel
- +1 more
Oct 3, 2019
Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Thailand (BP-C1, Placebo)
Completed
- Metastatic Breast Cancer
- Stage IV Breast Cancer
- BP-C1
- Placebo
-
Udon Thani, Udon Thani Province, Thailand
- +3 more
Oct 3, 2019
Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,
Completed
- Estrogen Receptor Negative
- +6 more
- Akt Inhibitor GSK2141795
- +2 more
-
Washington, District of Columbia
- +7 more
Aug 27, 2019
Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Chicago (cabergoline)
Completed
- Recurrent Breast Cancer
- Stage IV Breast Cancer
-
Chicago, IllinoisNorthwestern University
Sep 4, 2019
Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,
Completed
- Male Breast Cancer
- +2 more
- vorinostat
- +8 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019
Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,
Terminated
- Chemotherapeutic Agent Toxicity
- +11 more
- cryotherapy
- +4 more
-
Chicago, IllinoisNorthwestern University
Aug 16, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Male Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Houston (biological, drug, procedure, other)
Terminated
- Male Breast Cancer
- +4 more
- oblimersen sodium
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2019
Breast Tumor, Breast Cancer, Cancer of the Breast Trial in Worldwide (nab-Paclitaxel, Carboplatin, Gemcitabine)
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)
Completed
- Stage IA Breast Cancer
- +6 more
- educational intervention
- +4 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jan 23, 2019
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Recurrent Breast Carcinoma, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer Trial in United States (Akt Inhibitor MK2206,
Completed
- Recurrent Breast Carcinoma
- +3 more
- Akt Inhibitor MK2206
- +2 more
-
Boston, Massachusetts
- +4 more
Nov 28, 2018
Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)
Completed
- Male Breast Cancer
- +5 more
- ONTAK
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in
Completed
- Estrogen Receptor-negative Breast Cancer
- +5 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +2 more
-
Anchorage, Alaska
- +16 more
Nov 6, 2018
Breast Carcinoma Metastatic in the Bone, Circulating Tumor Cell Count, Estrogen Receptor Positive Trial in Chicago, Lake Forest
Terminated
- Breast Carcinoma Metastatic in the Bone
- +5 more
- Denosumab
- Laboratory Biomarker Analysis
-
Chicago, Illinois
- +1 more
Oct 22, 2018
Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer Trial in Bronx (fulvestrant,
Completed
- Estrogen Receptor-positive Breast Cancer
- +4 more
-
Bronx, New YorkMontefiore Medical Center
Oct 4, 2018
Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer Trial in Tucson
Completed
- Estrogen Receptor-positive Breast Cancer
- +4 more
- therapeutic estradiol
- +3 more
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Sep 21, 2018
Estrogen Receptor Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Rochester (Alisertib,
Completed
- Estrogen Receptor Positive
- +5 more
- Alisertib
- +2 more
-
Rochester, MinnesotaMayo Clinic
Oct 2, 2018
Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)
Terminated
- Cardiovascular Complications
- +7 more
- rosuvastatin
- +3 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 30, 2018
Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in New Orleans, Winston-Salem (biological, drug, procedure)
Terminated
- Breast Cancer
- +2 more
- panitumumab
- +4 more
-
New Orleans, Louisiana
- +1 more
Jul 3, 2018
Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)
Completed
- Stage I Breast Cancer
- +5 more
- questionnaire administration
- +5 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 2, 2018
Hyaluronic Acid in Causing Cancer Stem Cell Growth in Bones of
Withdrawn
- Breast Carcinoma Metastatic to the Bone
- Stage IV Breast Cancer
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jun 29, 2018